TNFRSF17 and plasma cell myeloma: The evidence from in-vitro and in-vivo studies indicates that overly expressed BCMA augments the proliferation and survival of malignant PCs and generates a bone marrow microenvironment that is conducive to myeloma cells proliferation (4).